Introduction Risks of extracorporeal membrane oxygenation (ECMO) therapy can be attributed to large membrane areas and blood circuit volumes. These are particularly problematic in neonates with low blood volume. To address this, we are developing a miniaturized prototype microfluidic ECMO…